Innovation comes in many forms, including new and expanded uses of existing medicines
By Emma Van Hook | January 29, 2018
2017 was a record-breaking year for new drug approvals, with the U.S. Food and Drug Administration (FDA) approving 56 new drugs and biologics. But the innovation did not stop there. As the FDA...
Read More
New report and event examine the new era of vaccines
By Andrew Powaleny | November 9, 2017
Today, leading minds will come together for an in-depth conversation centered on vaccines – their critical role in warding off disease, the innovative science powering breakthroughs in their...
Read More
A new era in cancer
By Andrew Powaleny | November 1, 2017
The last few years have seen unparalleled progress in cancer care, with breakthrough research driving major advances in diagnosis and treatment. Next week, on Wednesday, November 8, leading minds...
Read More
PhRMA, member companies and NIH create public-private partnership for immuno-oncology
By Andrew Powaleny | October 12, 2017
The rapid pace of scientific advances has helped usher in a new era of medicine for cancer patients over the last decade. This morning, the National Institutes of Health (NIH) took a significant...
Read More
2017 Research & Hope Awards honor innovators in mental health
By Hannah Mooney | October 10, 2017
Mental health disorders are a heavy human and economic burden in the United States. More than 40 million people across the country are impacted by mental illness, and it’s estimated that in any...
Read More
What they are saying: Study on cancer R&D costs is not an accurate representation of marketplace
By Holly Campbell | September 12, 2017
This post has been updated as of 10/2/2017 A recent study published in JAMA Internal Medicine provides flawed and inaccurate estimates of the significant research and development (R&D) investments...
Read More
How biopharmaceutical collaboration is driving a new era of medicine
By Andrew Powaleny | September 7, 2017
Biopharmaceutical innovation, coupled with technological advancements, has brought a new era of medicine transforming how we research and develop new medicines to benefit patients.
Read More
New PhRMA resources chock full of biopharma industry facts
By John Corea | July 20, 2017
Did you know that PhRMA member companies invested $65.5 billion in research and development (R&D) in 2016? Or that combined spending on brand medicines, generics and the supply chain account for...
Read More
Medicines have significantly increased chances of cancer survival around the globe
By Amey Sutkowski | May 24, 2017
Since a peak in 1991, cancer mortality rates have declined by as much as 27% around the world. These gains in cancer survival are largely attributed to new and innovative therapies. According to...
Read More
A new era in genomics
By Andrew Powaleny | April 26, 2017
Personalized medicine has taken on a new meaning with the mapping of the human genome.
Read More
Medicare Monday (100)
340B Spotlight (36)
Cost & Consequence (0)
